2020
DOI: 10.3389/fphys.2020.00387
|View full text |Cite
|
Sign up to set email alerts
|

Trends in the Development of Diagnostic Tools for Red Blood Cell-Related Diseases and Anemias

Abstract: Trends in the Development of Diagnostic Tools for Red Blood Cell-Related Diseases and Anemias.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 31 publications
0
16
0
Order By: Relevance
“…At the same time, the blood of patients with rare anemias was investigated ( Clark et al, 1980 ), and as the Technicon ektacytometers were replaced by the second generation Lorrca MaxSis devices produced by RR Mechatronics, scrupulous comparison of the readouts obtained by both types of devices was performed for blood of patients with hereditary hemolytic anemia. ( Da Costa et al, 2016 ; Lazarova et al, 2017 ; Ballas et al, 2018 ; Ciepiela, 2018 ; Llaudet-Planas et al, 2018 ; Zaninoni et al, 2018 ; Kaestner and Bianchi, 2020 ; Zaidi et al, 2020 ; Zama et al, 2020 ). The number of reports on the clinical applications of the device for the assessment of the changes in rheology for human patients is steadily growing.…”
Section: Introductionmentioning
confidence: 99%
“…At the same time, the blood of patients with rare anemias was investigated ( Clark et al, 1980 ), and as the Technicon ektacytometers were replaced by the second generation Lorrca MaxSis devices produced by RR Mechatronics, scrupulous comparison of the readouts obtained by both types of devices was performed for blood of patients with hereditary hemolytic anemia. ( Da Costa et al, 2016 ; Lazarova et al, 2017 ; Ballas et al, 2018 ; Ciepiela, 2018 ; Llaudet-Planas et al, 2018 ; Zaninoni et al, 2018 ; Kaestner and Bianchi, 2020 ; Zaidi et al, 2020 ; Zama et al, 2020 ). The number of reports on the clinical applications of the device for the assessment of the changes in rheology for human patients is steadily growing.…”
Section: Introductionmentioning
confidence: 99%
“…Understanding the spectrum of RBC shape deviations in 3D in blood diseases will allow to test unsupervised clustering methods to distinguish different mutations. While genetic analysis is the gold standard for detection, cell imaging can be of additional interest in the investigation of the severity and state of a disease [34]. Moreover, it can be applied for personalized theragnostics when the effectiveness of a mutations in the band 3 protein, as is P8, who also has a double mutation in spectrin alpha (see Table A in S1 Text), although this latter mutation is not known to be pathogenic.…”
Section: Discussionmentioning
confidence: 99%
“…This is the case for sickle cell disease, hereditary spherocytosis, and Gardos channelopathy, just to name a few examples. Some patients get scientists involved into a thrilling quest for the actual cause of disease, those that were identified by hematologists as carriers of “idiopathic hemolytic anemia.” New tools are currently in development that will enable the diagnosis of “newly identified” diseases ( Kaestner and Bianchi, 2020 ).…”
Section: With Inspiration and In Memory Of Douglas Adams And His Ultimentioning
confidence: 99%